Drug Shortage Report for TARO-CIPROFLOXACIN/DEXAMETHASONE
| Report ID | 150683 |
| Drug Identification Number | 02481901 |
| Brand name | TARO-CIPROFLOXACIN/DEXAMETHASONE |
| Common or Proper name | CIPRO/DEXA |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE CIPROFLOXACIN |
| Strength(s) | 0.1% 0.3% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OTIC |
| Packaging size | 7.5 |
| ATC code | S02CA |
| ATC description | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-26 |
| Estimated end date | 2024-05-25 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2022-09-16 | English | Compare |
| v9 | 2022-08-25 | French | Compare |
| v8 | 2022-08-25 | English | Compare |
| v7 | 2022-04-12 | French | Compare |
| v6 | 2022-04-12 | English | Compare |
| v5 | 2022-04-12 | English | Compare |
| v4 | 2022-01-06 | French | Compare |
| v3 | 2022-01-06 | English | Compare |
| v2 | 2021-12-07 | French | Compare |
| v1 | 2021-12-07 | English | Compare |